
"Traceability Technologies to Ensure Regulatory Compliance, Transparency and Visibility Across your Supply Chain"
Founded
1989
37 years
Employees
501-1000
Annual Revenue
Not Disclosed
(2026)
Products
1
Founded in 1989, OPTEL Group has 35+ years in traceability, track-and-trace, and vision systems, primarily serving the pharmaceutical industry, where it holds 25.7% market share in serialization systems per MarketsandMarkets.
OPTEL's product line spans the serialization technology stack: TrackSafe for site-level L1-L3 serialization and vision systems, VerifyBrand for enterprise L4-L5 cloud serialization software, and Optchain for ESG and supply chain sustainability. The company has 6,000+ systems installed worldwide, tracking 25 billion products annually, with a 96% customer satisfaction rating.
OPTEL is a Certified B Corporation. Founder and CEO Louis Roy established the company in Quebec City, Canada, after studying electrical engineering and physics, and received Canada's EY Entrepreneur of the Year award in 2017.
Pharmaceutical industry is OPTEL's primary focus, accounting for majority of business. Market leader in pharmaceutical serialization with 25.7% market share according to MarketsandMarkets, with 6,000+ systems tracking 25 billion products annually.
Named pharmaceutical customers include Pfizer, Johnson & Johnson, GSK, Teva, Sandoz, and Bayer - representing major Big Pharma and generics manufacturers. Solutions address DSCSA (US), EU FMD, and regulations in China, India, Russia, UAE, and other markets.
Dedicated pharmaceutical solutions include VerifyBrand enterprise serialization, TrackSafe site-level serialization, and vision inspection systems for pharmaceutical packaging. 96% customer satisfaction rating for service with 24/7 international technical support.
Industries Served
Privately funded, with total funding of approximately $12.9M per PitchBook. Investors include BDC (Business Development Bank of Canada), Fondaction, and Sustainable Development Technology Canada (SDTC).
Funding rounds: Private equity round from BDC and Fondaction (January 2023 - $13M), Grant from SDTC (May 2021 - $3.03M). Most recent unattributed round in January 2023.
In August 2025, OPTEL Group acquired Vanguard Robotics, which specialises in end-of-line collaborative robot (cobot) automation.
Browse all software products offered by OPTEL Group.
Three main product lines covering end-to-end supply chain traceability:
TrackSafe - Site-level serialization, aggregation, vision systems, and warehouse automation. Covers L1-L3 in the 5-level serialization architecture including physical equipment, line control software, and plant-level management across multiple production lines.
VerifyBrand - Enterprise-level L4-L5 cloud solution for serial number generation, EPCIS event management, and regulatory reporting. Features inventory tracking, product authentication, and partner portal for downstream visibility. Includes VerifyBrand FLEX variant.
Optchain - ESG and supply chain sustainability platform covering EUDR compliance, Digital Product Passport (DPP), CBAM, carbon tracking, and supplier risk management. Addresses emerging sustainability regulations.
Vision Systems - AI-powered inspection systems delivering 100% inspection capabilities for labels, packaging, and products. Integrated across manufacturing operations for quality verification.
Technology partnerships include SAP for enterprise integration and GS1 Standards membership for EPCIS and global traceability standards, alongside a Bureau Veritas partnership for verification services. OPTEL holds World Economic Forum membership and is a Certified B Corporation.
A global partnership agreement with Körber Pharma covers integrated serialization and track-and-trace solutions.
OPTEL acquired Vanguard Robotics in August 2025, adding end-of-line collaborative robot automation expertise to complement its serialization offerings.
Technology Partners
24/7 international technical support across all time zones with 2-hour response SLA. Most customers log fewer than one support ticket annually according to vendor.
Implementation services include five-phase deployment: consultation and site readiness, turnkey system design, integration and deployment, training and validation, and ongoing support with remote monitoring.
Validation services include IQ, OQ, Production IQ documentation, URS development, and CMO/3PL integration document authoring. Role-specific operator training with automated reports included.
Dedicated account management with turnkey partner integration for CMOs, 3PLs, and downstream partners. 96% customer satisfaction rating for service.
35+ years of industry expertise since 1989. Market leader in pharmaceutical serialization with 25.7% market share, 6,000+ systems installed globally.
Certified B Corporation since 2017. LEED-certified headquarters building in Quebec City.
Leadership: Louis Roy, Founder and CEO, received Canada's EY Entrepreneur of the Year award in 2017. Electrical engineering and physics background.
SOC 2 Type II certified for data security and operational reliability. Company has received "Dream Company to Work For" award at Stars of the Industry Awards.
6,000+ systems installed worldwide, tracking 25 billion products annually across 30+ countries. 46,500+ LinkedIn followers.
Active industry participation including CPHI Frankfurt 2025 exhibition (October 2025). Regular press releases covering product updates, partnerships, and acquisitions.
Multi-language website covering English, French, German, and other languages. Resource centre with whitepapers, blog content, regulation guides, and product documentation.
Publishes content on pharmaceutical serialization compliance, DSCSA, EU FMD, and supply chain sustainability topics.
Headquarters
Quebec City, Quebec, Canada
Founded
1989 (37 years in business)
Company Size
501-1000 employees
Type
Private
Owned by Not applicable - independent company
Annual Revenue
Not Disclosed (2026)
Office Locations
Global Reach
30 countries